With the recent ability to incorporate artificial intelligence (AI) and machine learning (ML) into many hard tech products, founders may not be aware of their position regarding data rights. Attorney Jason Novak, Partner at Norton Rose Fulbright, will walk founders through the potential data rights pitfalls and remedies for life sciences and hard tech companies. […]

Machine Learning (ML), data science, and bioinformatics are now incorporated into many hard tech products. Consultant Tomer Altman of Altman Analytics LLC, shares strategies to overcome the technical challenges involved in translating the research scale ML, data science, and bioinformatics tools to scaleable, commercial tools that can be incorporated into their product. Lunch is free and provided. Register […]

Bringing an innovative drug substance or the active pharmaceutical ingredient (API) to a Drug Product is a complex process and requires a clear definition of the Target Product Profile (TPP). Hear from Rajiv Nayar, PhD, President of HTD Biosystems, will define the critical items that need to be identified in the TPP before formulation development […]